Prestige Biologics amends annual report to add block tagging to financial statement notes
Bitget2026/09/28 06:29- Prestige Biologics filed a corrected annual report for FY2026 ended June 30, 2026, dated Sept. 28.
- The correction applied block-tagging to selected financial statement notes, including company overview, basis of preparation, and key accounting policies.
- No changes were disclosed to the underlying financial figures, business description, or other substantive report content.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
CNN Enters Generative AI Partnership with Google
US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening
As of press time, the stock is up more than 11%, trading at $17.77.
US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening
Amaero, a manufacturer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has gone public on the US stock market.
Crypto prices
More
